Company Profile
|
Biotest AG
(OTC: BTTAY)
|
5:48 PM UTC, 08/08/22 | |||
|---|---|---|---|---|
| Last: $24.27 | Change: +0.00 | %Change: +0.00% | Volume: 100 | |
Detailed Quote
M = Million B = Billion
Price Performance
Management Effectiveness
Profitability
| Open: | $ 24.27 | Volume: | 100 | |
|---|---|---|---|---|
| High: | $ 24.27 | Yield(%) | 0.00 | |
| Low: | $ 24.27 | P/E Ratio (ttm): | 9.44 | |
| Dividend ($): | n/a | Market Cap ($): | 905.39M | |
| EPS ($) | 2.42 | Shares Out: | 39.57M |
| % Price Change (last 4 weeks): | 1.12 |
|---|---|
| % Price Change (last 13 weeks): | 2.19 |
| % Price Change (last 26 weeks): | -0.90 |
| % Price Change (last 52 weeks): | -1.03 |
| % Price Change (year to date): | -2.76 |
| Return on Equity (%): | 28.99 |
|---|---|
| Return on Assets (%): | 9.44 |
| Return on Invested Capital (%): | -0.23 |
| Gross Profit Margin (%): | 39.72 |
|---|---|
| Net Profit Margin (%): | 18.55 |
| Operating Profit Margin (%): | 19.02 |
Price & Volume
Company Information
Per Share Data
Valuation Ratios
Financial Strength
|
|
|
| 50-day Moving Average: | $n/a |
|---|---|
| 200-day Moving Average: | $n/a |
| Avg. Daily Vol. (last 50 days): | n/a |
| Avg. Daily Vol. (last 200 days): | n/a |
| 52-wk high: | $n/a |
| 52-wk low: | $n/a |
| Bid: | $n/a |
| Ask: | $n/a |
|
Biotest AG engages in the development, manufacture, and marketing of plasma proteins and biotherapeutic drugs. It operates through the following segments: Therapy, Plasma and Services, and Other. The Therapy segment develops and produces blood plasma-based immunoglobulins, clotting factors, and albumins which are used to treat diseases of the immune system, haematological diseases, and in intensive care medicine. The Plasma and Services segment includes the areas of plasma sales and contract manufacturing. The Other segment refers to the merchandise business. The company was founded by Carl Adolf Schleussner and Hans Schleussner in 1946 and is headquartered in Dreieich, Germany.
|
|
Biotest AG
Landsteinerstrasse 5 Dreieich HE 63303 Phone: 49.6103.801.0 Fax: 49.6103.801.150 http://www.biotest.de |
| Earnings (1year) ($): | n/a |
|---|---|
| Annual Dividend ($): | 0.00 |
| Current P/E Ratio (ttm): | 9.44 |
| Book Value ($): | 6.96 |
| Cash Flow ($): | 4.45 |
| Price/Earnings (x): | 9.44 |
|---|---|
| Price/Sales (x): | 2.52 |
| Price/Book (x): | 3.38 |
| Price/Cash Flow (x): | n/a |
| Quick Ratio (x): | 0.88 |
|---|---|
| Current Ratio (x): | 1.96 |
| LT Debt/Equity (x): | 86.13 |
| Total Debt/Equity (x): | 138.26 |
